Slide 1
Slide 2
Slide 3
    What's Hot

    Viasat Launches Global “Space for Good Challenge 2025” to Inspire Future STEM Innovators

    July 9, 2025

    APQX Partners with Show Jumping Star Nathan Budd to Revolutionize Equestrian Performance Tech

    July 9, 2025

    Yingfa Ruineng Joins UN Global Compact to Accelerate Sustainable Photovoltaic Innovation

    July 9, 2025

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    Instagram YouTube LinkedIn
    UNI NETWORK GROUP
    • Sign In
    • Home
    • More
      • About Us
      • Advisory Council
      • Industries
        • Technology & Innovation
        • Startups and Entrepreneurship
        • Big Data Industry
        • BFSI
        • Healthcare & Biotech
        • Agriculture & Food Tech
        • Manufacturing
        • Automotive
        • AI Automation & Robotics
        • Academia & Industry
        • Transportation & Logistics
        • Government Focus
        • Infrastructure
      • Product Focus
      • Blog
      • Contact Us
    • People
    • Leadership
    • Women Special
    • Cover Story
    • R&D
    • L&D
    • Sustainability
    • Events
    • Magazine
    UNI NETWORK GROUP
    Facebook Twitter Instagram
    Home»Research & Development»Water Tower Research Spotlights Ainos’ AI Nose Programs and Strategic Milestones for 2025
    Research & Development

    Water Tower Research Spotlights Ainos’ AI Nose Programs and Strategic Milestones for 2025

    Editorial DeskBy Editorial DeskJanuary 28, 2025Updated:April 9, 2025No Comments6 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    January 21, 2025 (Newswire.com) – SAN DIEGO, CA / ACCESS NewswireAinos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”), a pioneer of digiting scent and low-dose interferon therapeutics, today announced that Water Tower Research (“WTR”) has published a report projecting increased visibility for the Company’s transformative AI Nose programs. The report emphasizes anticipated progress for AI Nose across multiple sectors, including robotics, smart manufacturing, elderly care, and women’s health.

    Key Highlights from the Report:

    Demo
    • AI Nose Technology: Ainos’ Flagship Innovation

    Robotics Integration: WTR noted that Ainos’s strategic focus on positioning its AI Nose technology as a critical sensory enhancement for robotics and humanoid applications. The Company is actively seeking partnerships to integrate olfactory capabilities, addressing a pivotal gap in robot functionality.

    Smart Manufacturing: In collaboration with Japanese partners, Ainos has developed a Volatile Organic Compounds (“VOC”) sensing program with nearly 80% accuracy in identifying 22 VOCs across 761 test samples at semiconductor factories. WTR highlighted Ainos’ plans for mass production by 1H2025, signaling significant potential in smart factory applications.

    Elderly Care Monitoring: The report emphasizes Ainos’ efforts to address Japan’s aging population with an AI-driven telehealth system for long-term care facilities. The system monitors the elderly’s hygiene and health by detecting VOCs linked to bowel movements and urine, with mass production also targeted for 1H2025. This program could facilitate the growing elderly care challenges in Japan’s aging population. By 2040, Japan is projected to face a shortfall of approximately 570,000 caregivers, with a third of its population aged 65 and older.

    Ainos Flora: Transforming Women’s Health Testing The first-generation Ainos Flora device, featuring non-invasive, handheld, portable, and reusable characteristics, demonstrated up to 94% accuracy in detecting vaginal infections and common sexually transmitted infections (“STIs”) during clinical trials. The second-generation Ainos Flora, optimized for at-home testing, is slated to begin clinical studies in 1H25. This development aligns with the growing demand for POCT, which currently represents approximately 31% of all STI tests, reflecting a large market opportunity.

    • VELDONA® Clinical Trials Remain on Track

    Clinical trials in Taiwan on Sjogren’s syndrome and HIV-related oral warts are expected to begin in 1H25, with completion anticipated in 2026. Animal health application for feline chronic gingivostomatitis (“FCGS”) is on track for completion in 1H25. Ainos plans to submit Investigational New Drug (“IND”) applications for U.S. trials by 2H25, paving the way for global therapeutic expansion.

    • Strategic Partnerships and Business Model

    WTR highlighted Ainos’ commitment to driving innovation while leveraging partnerships for manufacturing, distribution, and commercialization. This approach enables Ainos to focus its capital on product design and development. Ainos is actively engaging in discussions to establish partnerships for the Veldona program to advance the regulatory process and expand development across additional countries.

    Link to the WTR report

    About Ainos, Inc.
    Headquartered in San Diego, California, Ainos, Inc. develops disruptive medical and healthcare solutions based on its proprietary AI Nose and VELDONA® technologies. The name “Ainos” combines “AI” and “Nose” to signify the Company’s commitment to enabling AI with the ability to smell and individuals to live healthier. The Company’s clinical-stage product pipeline includes AI-driven, telehealth-friendly POCT solutions powered by AI Nose, VELDONA® human and animal oral therapeutics, and human orphan drugs. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.

    Safe Harbor Statement
    Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “approximate,” “expect,” “intend,” “plan,” “predict,” “project,” “target,” “future,” “likely,” “strategy,” “foresee,” “may,” “guidance,” “potential,” “outlook,” “forecast,” “should,” “will” or other similar words or phrases. Similarly, statements that describe the Company’s objectives, plans or goals are, or may be, forward-looking statements. Forward-looking statements are based only on the Company’s current beliefs, expectations, and assumptions. Forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results may differ materially from those indicated in the forward-looking statements.

    Important factors that could cause the Company’s actual results to differ materially from the projections, forecasts, estimates and expectations discussed in this press release include, among others, the cost of production and sales potential of the products announced in this press release; the Company’s dependence on projected revenues from the sale of current or future products; the Company’s limited cash and history of losses; the Company’s ability to achieve profitability; the Company’s ability to raise additional capital to continue the Company’s product development; the ability to accurately predict the future operating results of the Company; the ability to advance Ainos’ current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates the Company develops; the ability to obtain and maintain regulatory approval of Ainos’ product candidates; delays in completing the development and commercialization of the Company’s current and future product candidates, which could result in increased costs to the Company, delay or limit the ability to generate revenue and adversely affect the business, financial condition, results of operations and prospects of the Company; intense competition and rapidly advancing technology in the Company’s industry that may outpace its technology; customer demand for the products and services the Company develops; the accuracy of third-party market research data, the impact of competitive or alternative products, technologies and pricing; disruption in research and development facilities; lawsuits and other claims by third parties or investigations by various regulatory agencies governing the Company’s operations; potential cybersecurity attacks; increased requirements and costs related to cybersecurity; the Company’s ability to realize the benefits of third party licensing agreements; the Company’s ability to obtain and maintain intellectual property protection for Ainos product candidates; compliance with applicable laws, regulations and tariffs; continued listing on and compliance with the applicable regulations of the Nasdaq Capital Market; and the Company’s success in managing growth. A more complete description of these risk factors and others is included in the “Risk Factors” section of Ainos’ Annual Report on Form 10-K for the year ended December 31, 2023, and other public filings with the U.S. Securities and Exchange Commission (“SEC”), many of which risks are beyond the Company’s control. In addition to the risks described above and in the Company’s filings with the SEC, other unknown or unpredictable factors also could cause actual results to differ materially from the projections, forecasts, estimates and expectations discussed in this press release.

    The forward-looking statements made in this press release are expressly qualified in their entirety by the foregoing cautionary statements. Any forward-looking statements contained in this press release represent Ainos’ views only as of today and should not be relied upon as representing its views as of any subsequent date. Ainos undertakes no obligation to, and expressly disclaims any such obligation to, publicly update or revise any forward-looking statement to reflect changed assumptions, the occurrence of anticipated or unanticipated events or changes to the future results over time or otherwise, except as required by law.

    Demo
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Editorial Desk
    • Website

    Demo

    Related Posts

    Global Geomarketing Market Set to Reach $78.9 Billion by 2031, Driven by Location Intelligence and AI Adoption

    July 1, 2025

    MIT’s Electronic Skin Could Power Lightweight Night Vision Glasses

    April 25, 2025

    Fuel Cells Take Flight: UConn’s Clean Aviation Tech Makes a Bold Entrance

    April 25, 2025

    Leave A Reply Cancel Reply

    Top Posts

    Viasat Launches Global “Space for Good Challenge 2025” to Inspire Future STEM Innovators

    July 9, 2025

    APQX Partners with Show Jumping Star Nathan Budd to Revolutionize Equestrian Performance Tech

    July 9, 2025

    Yingfa Ruineng Joins UN Global Compact to Accelerate Sustainable Photovoltaic Innovation

    July 9, 2025

    Woman Evolve 2025: Sarah Jakes Roberts Leads Sold-Out Global Gathering on Faith, Freedom, and Female Empowerment

    July 9, 2025
    Don't Miss
    Cover Story

    The Rise of AI Bosses: Innovation or Overhyped Experiment?

    By Editorial DeskMarch 6, 20250

    The rise of AI CEOs is undeniably intriguing, but it’s far from a straightforward revolution.…

    Google Announces Quantum Computing Breakthrough with 1000 Qubits

    February 19, 2025

    New Harvard Business Review Report Urges HR Leaders to Embrace AI and Bridge Critical Talent Gaps

    June 27, 2025

    Data Center Construction Boom: Powering the Future of AI Infrastructure

    May 19, 2025

    SUBSCRIBE TO OUR NEWSLETTER

    From our editors straight to your inbox

    ONE STORY AT A TIME

    Social Media Post

    Linkedin

    Linkedin

    Larry Dawson Page’s Next Big Bet: AI-Driven Product Manufacturing with Dynatomics

    Linkedin

    Linkedin

    Exciting Leadership & Strategic Wins at Wipro!

    Linkedin

    Linkedin

    She Codes the Future: Dr. Joy Buolamwini – Fighting Bias in AI

    Linkedin

    Linkedin

    Hugging Face Strengthens AI Security with JFrog Integration

    Watch

    AI Automation & Robotics

    Google DeepMind’s AI: Revolutionizing Biotechnology

    Biotechnology is entering a new era with Google DeepMind’s AI…

    Read More
    Academia & Industry

    MIT and Google: Shaping the Future of Quantum Computing Education

    Quantum computing is poised to revolutionize industries, from healthcare to…

    Read More
    Learning & Development

    Reskilling older workers for new careers in tech

    June 10, 2022They won’t catch on to the technology. They’ll have…

    Read More
    Agriculture & Food Tech

    Nestlé Invests $1 Billion in Sustainable Coffee Farming

    Coffee is one of the world’s most beloved beverages, and…

    Read More
    Sustainability

    AMD 2023-24 Corporate Responsibility Report: Advancing Sustainability, Collaboration and Inclusion

    SANTA CLARA, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) — Today,…

    Read More
    Women Special

    Data Divas: How Women Are Harnessing Data to Drive Social Change

    Data is often called the new oil, but unlike oil,…

    Read More
    Transportation & Logistics

    Maersk North America Market Update – May 2025: Navigating a Transforming Supply Chain Landscape

    This comprehensive update sheds light on the evolving dynamics of…

    Read More
    Healthcare & Biotech

    Johnson & Johnson’s AI Surgical Robot: Revolutionizing Precision Surgery

    Surgery is becoming more precise and efficient with Johnson &…

    Read More
    Automobile

    U.S. Delays Tariffs on Mexico & Canada – What’s Behind the 30-Day Pause?

    The U.S. has hit pause on imposing 25% tariffs on…

    Read More

    About Us

    • Uni Network Group
    • Advisory Council
    • Why Uni Network Group

    Downloads

    • Media Pack
    • Industry reports
    • Blogs

    Career

    • Professionals
    • Freelancer
    • Students

    Contact us

    • Editorial coverage
    • Speaker opportunity
    • General enquiries
    • Advertise with us

    UNI NETWORK GROUP

    Kickstart your day with powerful tech insights and bite-sized news—all packed into a crisp 5-minute read, straight to your inbox!

    For latest industries update Subscribe newsletter.

      Advertise with Newsletter  

      Follow Us

      Linkedin X-twitter Facebook Instagram Youtube

      Copyright © 2025 UNI NETWORK GROUP. All rights reserved.

      • About Us
      • Privacy Policy
      • Career
      • Terms & Condition